Today: 14 March 2026
Browse Category

Stock Market 11 December 2025

TELUS Stock Hits New 12‑Month Low After BMO Downgrade — What a 9% Dividend and Deleveraging Plan Mean for Investors

TELUS Stock Hits New 12‑Month Low After BMO Downgrade — What a 9% Dividend and Deleveraging Plan Mean for Investors

TELUS shares hit a new 12-month low near C$17.75 on December 11 after BMO Capital Markets downgraded the stock and cut its price target to C$19. The move followed TELUS’s decision to pause dividend growth and launch a deleveraging plan. The stock now yields about 9.4%, but analysts flagged concerns over valuation, payout ratios, and uncertainty around TELUS Digital.
Arm Holdings (ARM) Stock on December 11, 2025: Oracle Shock, 200‑Day Breakdown and the AI Growth Story

Arm Holdings (ARM) Stock on December 11, 2025: Oracle Shock, 200‑Day Breakdown and the AI Growth Story

Arm Holdings shares fell about 5% to $135 on December 11, 2025, after dropping below their 200-day moving average. The decline followed a sharp sell-off in Oracle and renewed concerns about AI sector profitability, which hit AI-related stocks across markets. Arm recently reported 34% revenue growth and strong forecasts, but trades at high earnings multiples. Wall Street’s average price target remains near $180.
Onto Innovation (ONTO) Stock on December 11, 2025: Latest Price, Q3 Earnings, Semilab Deal and 2026 Forecasts

Onto Innovation (ONTO) Stock on December 11, 2025: Latest Price, Q3 Earnings, Semilab Deal and 2026 Forecasts

Onto Innovation shares fell 5% to around $160 Thursday after recent short-interest data and the closing of a $495 million acquisition. The company reported Q3 revenue of $218.2 million, down 13.5% year-over-year, but posted a small earnings beat. Market cap stands near $8 billion. The stock’s 12-month range is $85.88 to $228.42.
Super Micro Computer (SMCI) Stock Today: AI Server Leader Faces Margin Squeeze — Latest News, Forecasts and Analysis

Super Micro Computer (SMCI) Stock Today: AI Server Leader Faces Margin Squeeze — Latest News, Forecasts and Analysis

Super Micro Computer shares traded near $33 on December 11, down 5–6% intraday and about 9% over the past year, lagging sector peers. The stock has slumped amid a 15.5% revenue drop, 56–60% earnings decline, and negative free cash flow of $950 million in fiscal Q1 2026. Investors cite margin pressure, regulatory concerns, and execution risks as key issues.
EchoStar (SATS) Stock News and Forecast After November 21, 2025: SpaceX Deal, AT&T Spectrum and Analyst Targets

EchoStar (SATS) Stock News and Forecast After November 21, 2025: SpaceX Deal, AT&T Spectrum and Analyst Targets

EchoStar shares surged from $68.63 on November 21, 2025, to the low-$100s by December 11, near all-time highs. The stock is up about 190% year-over-year, driven by major spectrum deals with SpaceX and AT&T and speculation over a SpaceX IPO. On November 21, COO John Swieringa sold 22,000 shares for $1.48 million, while a Schedule 13G filing revealed new institutional interest.
DoorDash (DASH) Stock Forecast After the Q3 2025 Selloff: Price Targets, 2026 Outlook and Key Risks

DoorDash (DASH) Stock Forecast After the Q3 2025 Selloff: Price Targets, 2026 Outlook and Key Risks

DoorDash traded near $220.90 midday Dec. 11, 2025, rebounding from late-November lows but still below its $285 high. Q3 revenue rose 27% to $3.45 billion and orders climbed 21%, but an EPS miss and guidance for higher 2026 spending triggered a sharp selloff. The stock is up nearly 30% over 12 months. Analysts maintain long-term targets near $260–$280 despite regulatory and competitive risks.
Biggest Stock Losers Today in the U.S. Market (December 11, 2025): Oracle’s AI Reality Check, Rezolute’s Trial Disaster and Micro‑Cap Carnage

Biggest Stock Losers Today in the U.S. Market (December 11, 2025): Oracle’s AI Reality Check, Rezolute’s Trial Disaster and Micro‑Cap Carnage

Oracle shares dropped 13% intraday after a revenue miss and surging AI spending, erasing tens of billions in value and pulling the Nasdaq 100 down 0.8%. Small-cap stocks including Rezolute, C3is, and GRI Bio plunged up to 90% on clinical failures and delisting threats. The Dow rose 1.3% to record levels. The S&P 500 slipped 0.1%.
T-Mobile (TMUS) Stock Outlook After the November 21 Downgrade: Price War Fears, 5G Growth and a Bigger Dividend

T-Mobile (TMUS) Stock Outlook After the November 21 Downgrade: Price War Fears, 5G Growth and a Bigger Dividend

T-Mobile shares traded near $195 on December 11, 2025, down about 29% from their March high and close to a one-year low. The stock fell sharply after Oppenheimer downgraded it on November 21, citing fears of a price war and slower subscriber growth. TMUS underperformed the S&P 500 and major peers in recent sessions. Market cap stands at roughly $218 billion.
Verizon (VZ) Stock Outlook December 2025: Job Cuts, Big Dividend and Mixed Wall Street Forecasts

Verizon (VZ) Stock Outlook December 2025: Job Cuts, Big Dividend and Mixed Wall Street Forecasts

Verizon shares closed at $40.21 on December 11, 2025, below their 200-day moving average and most analyst targets. The company is cutting over 13,000 jobs in its largest layoff ever and named Dan Schulman as CEO. The annual dividend stands at $2.76 per share, yielding nearly 6.9%. Investors have kept the stock in a narrow range since the restructuring was announced.
11 December 2025
10x Genomics (TXG) Stock: Citi Downgrade, AI Partnerships and 2026 Forecast After December 11 Sell-Off

10x Genomics (TXG) Stock: Citi Downgrade, AI Partnerships and 2026 Forecast After December 11 Sell-Off

10x Genomics shares fell over 6% to the mid-$16 range on December 11, 2025, after Citigroup downgraded the stock from Buy to Neutral, maintaining an $18 price target. The company’s market cap stands near $2.2 billion. Despite the drop, shares remain up more than 20% year to date. Analyst consensus now leans Hold, with average 12-month price targets around $15–17.
Vertiv (VRT) Stock Pulls Back After Wolfe Downgrade – Can the AI Data Center Winner Keep Climbing in 2026?

Vertiv (VRT) Stock Pulls Back After Wolfe Downgrade – Can the AI Data Center Winner Keep Climbing in 2026?

Vertiv shares fell about 7% to $169–170 by midday December 11, 2025, after missing S&P 500 inclusion and a downgrade from Wolfe Research. The stock has lost ground from last month’s record near $199. Wolfe cited valuation concerns following a steep rally since 2022. Vertiv remains up over 50% year-to-date, with Q3 net sales up 29% and raised 2025 guidance.
11 December 2025
GE Aerospace Stock in December 2025: Latest News, Dividend Update, and 2026 Forecast After the November Rally

GE Aerospace Stock in December 2025: Latest News, Dividend Update, and 2026 Forecast After the November Rally

GE Aerospace traded near $285–286 per share late morning December 11, with a market cap around $300 billion. The stock is up about 72% year-to-date, far outpacing the aerospace sector’s 27% gain. Insider selling by a senior executive on November 21 triggered a brief 1.1% dip, but institutional investors have continued adjusting positions without a major exodus.
11 December 2025
Telix Pharmaceuticals (TLX) Stock: Varian Deal, ProstACT Milestone and Class Actions Redraw the 2025 Outlook

Telix Pharmaceuticals (TLX) Stock: Varian Deal, ProstACT Milestone and Class Actions Redraw the 2025 Outlook

Telix Pharmaceuticals shares fell 6% to US$9.33 in New York on December 11, near a 52-week low, despite trailing 12-month revenue of US$664 million and a new clinical partnership with Varian. The company faces SEC scrutiny, an FDA setback, and multiple class-action lawsuits, but continues to report late-stage oncology progress and expanding collaborations.
Affirm Holdings (AFRM) Stock on December 11, 2025: Shopify Expansion, Institutional Buying and Lofty Price Targets Put BNPL Leader Back in Focus

Affirm Holdings (AFRM) Stock on December 11, 2025: Shopify Expansion, Institutional Buying and Lofty Price Targets Put BNPL Leader Back in Focus

Affirm Holdings closed at $70.86 on December 10, 2025, more than doubling from its April low of $30.90 but still below its August peak near $100. The company reported fiscal Q1 2026 earnings of $0.23 per share on $933.3 million in revenue, beating expectations. Affirm now counts over 24 million active consumers and 419,000 merchant partners. Shares remain volatile as investors weigh profitability and sector competition.
11 December 2025
Analog Devices (ADI) Stock Near Record Highs After Q4 2025 Beat: Earnings, Forecasts and What Comes Next

Analog Devices (ADI) Stock Near Record Highs After Q4 2025 Beat: Earnings, Forecasts and What Comes Next

Analog Devices closed at $280.50 on December 11, 2025, less than 1% below its 52-week high after posting strong Q4 and full-year results on November 25. Fiscal 2025 revenue rose 17% to $11 billion, with Q4 EPS of $2.26 topping estimates. Shares gained nearly 4% after the report and upbeat guidance for fiscal 2026.
AI Stocks Today: Oracle’s 13% Crash Reignites AI Bubble Fears as Nvidia, AMD and Micron Slide (December 11, 2025)

AI Stocks Today: Oracle’s 13% Crash Reignites AI Bubble Fears as Nvidia, AMD and Micron Slide (December 11, 2025)

Oracle shares plunged 13–14% on Thursday after missing revenue forecasts and raising 2026 AI spending plans by $15 billion to $50 billion. The sell-off triggered declines in major AI stocks, with Nvidia down about 3.5% and AMD off roughly 3%. The Nasdaq fell 1% by mid-session, while the Dow hit a record high as investors shifted into traditional blue chips.
Big Tech Stocks Today: Oracle’s AI Shock Knocks Nasdaq While Dow Hits Record (December 11, 2025)

Big Tech Stocks Today: Oracle’s AI Shock Knocks Nasdaq While Dow Hits Record (December 11, 2025)

Oracle shares plunged 13–14% Thursday after weak revenue and sharply higher AI spending guidance, erasing over $100 billion in value and dragging the Nasdaq down 1%. The S&P 500 slipped 0.3%, while the Dow hit a record high, up 1%. Nvidia fell 3.3%. Microsoft rose 0.2%.

Stock Market Today

  • Becton Dickinson (BDX) Stock Seen Undervalued Amid Recent Price Declines
    March 14, 2026, 1:04 PM EDT. Becton Dickinson's shares dropped 4.6% last week and 18.3% year to date, sparking questions about its market valuation. A Discounted Cash Flow (DCF) analysis estimates an intrinsic value of $218.65 per share, indicating the stock is trading roughly 27.1% below fair value. The company's latest free cash flow stands at $2.60 billion, with analyst forecasts projecting growth to $3.73 billion by 2030. Becton Dickinson's price-to-earnings (P/E) ratio of 25.83 is near the Medical Equipment industry average, reflecting current investor expectations. These metrics suggest a potential buying opportunity for long-term investors watching shifts in healthcare supplier valuations.
Go toTop